| |
| |
|
| Insider
Information: |
Economides Vassiliki |
| Relationship: |
|
| City: |
South San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
235,332 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$181,013 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
235,332 |
|
|
| Total
Value |
$181,013 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Kezar Life Sciences, Inc. |
KZR |
SVP, Strategy & Extern... |
2020-02-04 |
7,570 |
|
0 |
Premium* |
|
|
Gritstone Oncology, Inc. |
GRTS |
|
2024-02-01 |
227,762 |
2022-01-31 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
9 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| GRTS |
Gritstone Oncology, Inc. |
EVP, CHIEF FINANCIAL OFFICER |
• – – |
2024-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
35,000 |
227,762 |
0 |
- |
|
| GRTS |
Gritstone Oncology, Inc. |
See Remarks |
• – – |
2023-05-23 |
4 |
B |
$1.90 |
$22,829 |
D/D |
12,000 |
214,058 |
2.74 |
% |
|
| GRTS |
Gritstone Oncology, Inc. |
See Remarks |
• – – |
2023-02-02 |
4 |
A |
$0.00 |
$0 |
D/D |
179,058 |
202,058 |
0 |
- |
|
| GRTS |
Gritstone Oncology, Inc. |
EVP & CFO |
• – – |
2022-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
23,000 |
23,000 |
0 |
- |
|
| KZR |
Kezar Life Sciences, Inc. |
SVP, Strategy & External Aff. |
• – – |
2020-02-04 |
4 |
B |
$2.60 |
$14,999 |
D/D |
5,769 |
7,570 |
2.74 |
% |
|
| KZR |
Kezar Life Sciences, Inc. |
SVP, Strategy & External Aff. |
• – – |
2019-08-20 |
4 |
B |
$4.41 |
$1,544 |
D/D |
350 |
1,801 |
2.66 |
- |
|
| KZR |
Kezar Life Sciences, Inc. |
SVP, Strategy & External Aff. |
• – – |
2019-08-09 |
4 |
B |
$4.96 |
$5,057 |
D/D |
1,020 |
1,451 |
2.74 |
- |
|
| KZR |
Kezar Life Sciences, Inc. |
SVP, Strategy & External Aff. |
• – – |
2019-07-22 |
4 |
B |
$5.82 |
$2,509 |
D/D |
431 |
431 |
2.66 |
- |
|
| KZR |
Kezar Life Sciences, Inc. |
SVP, Strategy & External Aff. |
• – – |
2019-05-30 |
4 |
B |
$10.19 |
$7,643 |
D/D |
750 |
11,320 |
2.74 |
- |
|
9 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
